Skip to main content
SEMHF logo

Siemens Healthineers AG (SEMHF) Stock Price & Analysis

Siemens Healthineers AG (SEMHF) — price $48.14 (+1.13%), as of the Nov 19, 2026 trading session; market cap $53.9B.

Educational signal · not a buy or sell recommendation · How to read this

$48.14 +$0.538 (+1.13%) Market Cap $53.9B

Siemens Healthineers AG · SEMHF · Healthcare · Medical - Devices

Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide.

Price as of Nov 19, 2026

Key Statistics

No MoonshotScore yet: we have not published a score for this company.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • EW · Edwards Lifesciences Corporation · 93 /100
  • BSX · Boston Scientific Corporation · 77 /100
  • DXCM · DexCom, Inc. · 93 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$48.14
Change on the day+1.13%
52-week range$37.00–$56.39
Market capitalisation$53.9B—
Price / earnings (trailing)21.87
Shares traded on the day211
Beta (volatility vs the S&P 500)0.83

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $39, high $58, latest $48. $58 $39 high $58 Oct 17, 2025 Nov 19, 2026 · $48 $54Oct 17, 2025$54Oct 31, 2025$52Nov 14, 2025$51Nov 28, 2025$53Dec 12, 2025$52Dec 26, 2025$56Jan 9, 2026$50Jan 23, 2026$50Feb 6, 2026$51Feb 20, 2026$48Mar 6, 2026$42Mar 20, 2026$42Apr 2, 2026$44Apr 17, 2026$41May 1, 2026$39May 15, 2026$40May 29, 2026$39Jun 12, 2026$39Jun 26, 2026$39Jul 10, 2026$40Jul 24, 2026$47Aug 7, 2026$48Aug 21, 2026$45Sep 4, 2026$45Sep 18, 2026$44Oct 2, 2026$48Oct 16, 2026$48Oct 30, 2026$49Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Siemens Healthineers AG (SEMHF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Neutral
Revenue Growth Neutral
Debt/Equity Weak
ROE Neutral
Gross Margin Neutral

Read on: Aug 22, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Aug 22, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Siemens Healthineers AG (SEMHF), and what does it report?

Short answer

Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide. Healthcare / Medical Devices Headquarters: Siemensstr. 3, Forchheim, BV, 91301, DE. It employs 74,600 people and is led by Bernhard Montag. In Q4 FY2026 it reported revenue of €6.78B and net income of €589M. The market values it at $53.9B.

2 · Latest results

What do the latest results show for Siemens Healthineers AG (SEMHF)?

Short answer · as of

The most recent reported quarter, Q4 FY2026, carried revenue of €6.78B. Against analyst estimates the company has EPS beat 4 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2026€6.78B€589M€0.53 (diluted)
Q3 FY2026€5.76B€668M€0.59 (diluted)
Q2 FY2026€5.70B€508M€0.45 (diluted)
Q1 FY2026€5.40B€450M€0.40 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Siemens Healthineers AG (SEMHF)?

Short answer · as of

The distress and quality screens read Altman Z 2.03 · Piotroski F 7. Trailing ratios: ROE 11.7% · ROA 4.7% · current ratio 1.18 · earnings yield 4.5% · free-cash-flow yield 4.1%.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held SEMHF in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported SEMHF in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Siemens Healthineers AG (SEMHF)?

Read these with our analysis →

What Investors Ask About Siemens Healthineers AG (SEMHF) — Healthcare

These answers are editorial: 1 of these 8 answers is drawn from the SEMHF research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is SEMHF a good stock to buy?

Stock Expert AI does not rate SEMHF buy, sell or hold. Siemens Healthineers AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the SEMHF stock price today?

The last price recorded for Siemens Healthineers AG (SEMHF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What does Siemens Healthineers AG do?

Siemens Healthineers AG is a leading medical technology company that develops, manufactures, and sells a comprehensive range of diagnostic and therapeutic products and services to healthcare providers worldwide.

What are the key factors to evaluate for SEMHF?

Evaluate SEMHF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. The company's expertise in medical technology and healthcare workflows positions it well to capitalize on this trend. Not financial advice.

How frequently does SEMHF data refresh on this page?

SEMHF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven SEMHF's recent stock price performance?

Siemens Healthineers AG (SEMHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive portfolio of diagnostic and therapeutic products and services. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SEMHF overvalued or undervalued right now?

The trailing P/E of Siemens Healthineers AG (SEMHF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research SEMHF before investing?

Before investing in Siemens Healthineers AG (SEMHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 19 figures on this page — 15 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.